Overalls

RiverNorth Closed-End Funds Declare Monthly Distributions

Retrieved on: 
Monday, April 1, 2024

Each Fund maintains a level distribution policy with the intention of providing monthly distributions to shareholders at a constant and fixed (but not guaranteed) rate that is reset annually.

Key Points: 
  • Each Fund maintains a level distribution policy with the intention of providing monthly distributions to shareholders at a constant and fixed (but not guaranteed) rate that is reset annually.
  • Each Fund’s ability to maintain a stable level of distributions to shareholders will depend on a number of factors, including changes in the financial market, market interest rates, and performance of overall equity and fixed income markets.
  • Holders of each Fund’s common stock will receive the distribution under one of two options:
    2.
  • A return of capital does not necessarily reflect a Fund’s investment performance and should not be confused with ‘yield’ or ‘income.’ Any such returns of capital will decrease a Fund’s total assets and, therefore, could have the effect of increasing a Fund’s expense ratio.

Global Pet Care Market Outlook & Forecast Report 2022-2024 & 2024-2028 Featuring Prominent Vendors - Nestle Purina, Mars, and J.M Smucker Co - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 28, 2024

The "Global Pet Care Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pet Care Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global pet care market is expected to surpass $400 billion by 2028 from $295 billion in 2022, growing at a CAGR of 5.22%
    The global pet care market is highly fragmented as multiple players exist across various market attributes.
  • North America holds the most prominent share of the global pet care market, accounting for over 49% in 2022.
  • The dry pet food segment dominated the global pet care market, accounting for a share of over 42% in 2022.

Community Health Systems Addresses Health Disparities through Doctors’ Day Donations and Second Annual Jars of Love Peanut Butter Drive

Retrieved on: 
Thursday, March 28, 2024

Doctors’ Day is an annual observance that honors physicians worldwide for their unwavering commitment to providing high-quality healthcare for individuals and communities.

Key Points: 
  • Doctors’ Day is an annual observance that honors physicians worldwide for their unwavering commitment to providing high-quality healthcare for individuals and communities.
  • Peanut butter, known for its nutritional value and long shelf life, is among the most requested items by food banks.
  • CHS-affiliated health systems collected more than 86,000 jars of peanut butter and other nut butters to donate to 58 local food banks.
  • We’re also extremely grateful for the generosity of employees, physicians and community members who joined in our efforts to create greater health equity by supporting our Jars of Love Peanut Butter Drive this year,” said Hingtgen.

CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
Thursday, March 28, 2024

CVD Equipment Corporation (NASDAQ: CVV ), today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • CVD Equipment Corporation (NASDAQ: CVV ), today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.
  • Manny Lakios, President and CEO of CVD Equipment Corporation, commented, “Fourth quarter 2023 revenue was $4.1 million, down significantly versus the prior year period, as our business continues to experience fluctuations in revenue given the nature of the emerging growth end markets we serve.
  • This represents an important milestone for CVD, with potential follow-on production orders should our equipment effectively meet the customers’ needs.
  • Orders for the fourth quarter were $5.8 million driven by continued demand in the aerospace sector and in our SDC segment for gas delivery equipment.

Long-Acting Drug Delivery Technologies and Services Market, 2033: Patient-Centric Approaches Fueling Growth, Small Molecules Dominate, Biopharmaceutical and Life Science Companies Lead - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 28, 2024

As of 2022, the global long-acting drug delivery technologies and services market held a value of $11.41 billion.

Key Points: 
  • As of 2022, the global long-acting drug delivery technologies and services market held a value of $11.41 billion.
  • The global long-acting drug delivery technologies and services market (by type of molecule delivered) was dominated by the small molecules segment in FY2022.
  • The Biopharmaceutical and Life science Companies segment accounted for the largest share of the global long-acting drug delivery technologies and services market (by End User) in FY2022.
  • Biopharmaceutical and life science companies are poised to sustain their dominant role in the global long-acting drug delivery technologies and services market as primary end users.

CI&T Named in Everest Group’s Global Retail IT Services and CPG IT Services PEAK Matrix® Assessments 2024

Retrieved on: 
Wednesday, March 27, 2024

CI&T (NYSE: CINT), a leader in driving AI-powered digital transformation for global brands, announced today it was recognized by leading research firm Everest Group in two new global reports for 2024.

Key Points: 
  • CI&T (NYSE: CINT), a leader in driving AI-powered digital transformation for global brands, announced today it was recognized by leading research firm Everest Group in two new global reports for 2024.
  • CI&T was named a Major Contender in the Consumer Packaged Goods (CPG) IT Services PEAK Matrix® and an Aspirant in the Retail IT Services PEAK Matrix® for 2024.
  • "As we reflect on our successes with our valued CPG and Retail clients, we're energized by the momentum we've built together," said Marcelo Vessoni, SVP, Head of Retail, CI&T.
  • In addition, CI&T was recognized as an Aspirant by Everest Group for the Retail Services IT PEAK Matrix Assessment 2024 which examined 24 providers.

New Report Highlights Critical Gap Between Employees and Executives Around Generative AI Leadership Readiness

Retrieved on: 
Wednesday, March 27, 2024

When pressed about their leadership team’s GenAI readiness, including their approach to risk mitigation and overall communication, employees consistently gave low ratings to their executives.

Key Points: 
  • When pressed about their leadership team’s GenAI readiness, including their approach to risk mitigation and overall communication, employees consistently gave low ratings to their executives.
  • As early adopters of GenAI, employees across the technology, professional services, and financial services sectors consistently rate their leadership team’s readiness, communication, and management of GenAI more positively.
  • “Effective leadership is crucial for companies to navigate transformation and thrive in a changing landscape,” said Greg Brown, President and CEO at Udemy.
  • As part of this programming, there are three critical GenAI imperatives that Udemy can help leadership teams address:
    Becoming familiar with the technology.

CareQuest Innovation Partners and MATTER Open Applications for SMILE Health, Seeking Innovators Bridging the Medical-Dental Divide

Retrieved on: 
Wednesday, March 27, 2024

CareQuest Innovation Partners , a company focused on validating and scaling transformative solutions to improve overall health through oral health for all, in partnership with MATTER , the premier health care incubator and innovation hub, today announced applications are open for SMILE Health.

Key Points: 
  • CareQuest Innovation Partners , a company focused on validating and scaling transformative solutions to improve overall health through oral health for all, in partnership with MATTER , the premier health care incubator and innovation hub, today announced applications are open for SMILE Health.
  • SMILE Health advances solutions to help address this gap by bringing together innovators with industry partners and investors.
  • Reducing Disparities through Oral Health: How can we leverage innovative oral health solutions to better identify and/or address health disparities?
  • We are thrilled to continue our collaboration with CareQuest Innovation Partners to build this year’s program,” said Steven Collens, CEO of MATTER.

Tech Alert: Using Connection Brokers in Parallel IT Systems

Retrieved on: 
Tuesday, March 26, 2024

Connection brokers can be indispensable intermediaries in parallel IT systems, serving multiple functions beyond remote desktop tasks including resource allocation, access control, and policy enforcement.

Key Points: 
  • Connection brokers can be indispensable intermediaries in parallel IT systems, serving multiple functions beyond remote desktop tasks including resource allocation, access control, and policy enforcement.
  • Their ability to orchestrate and manage resources in parallel IT environments helps deliver continuity, resilience, and flexibility.
  • “Organizations need sophisticated tools to manage parallel IT systems with agility and efficiency, and connection brokers like Leostream’s bridge the gap between virtualized infrastructures and cloud-based resources,” said Leostream CEO Karen Gondoly.
  • In parallel IT systems built on vSphere and AWS, Leostream’s connection broker can unify, optimize, and simplify the management of diverse resources across both on-premises and cloud environments.

Renesas Introduces Industry’s First General-Purpose 32-bit RISC-V MCUs with Internally Developed CPU Core

Retrieved on: 
Tuesday, March 26, 2024

Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced the industry’s first general-purpose 32-bit RISC-V-based microcontrollers (MCUs) built with an internally developed CPU core.

Key Points: 
  • Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced the industry’s first general-purpose 32-bit RISC-V-based microcontrollers (MCUs) built with an internally developed CPU core.
  • Similar to existing general-purpose MCUs, designers will have access to a full-scale development environment for the R9A02G021, provided by Renesas and its extensive network of toolchain partners.
  • The R9A02G021 group represents the first generation of general- purpose MCUs based on the internally developed RISC-V core by Renesas that will roll out over the next several years.
  • The R9A02G021 RISC-V MCUs are fully supported by Renesas’ e² studio Integrated Development Environment (IDE), offered to customers at no cost.